Sunshine Biopharma Inc. (SBFMW) Net margin 2019–2025
Sunshine Biopharma Inc. (SBFMW) net profit margin by fiscal year — reported net income divided by reported revenue.
-16.5%FY2025 · since FY2019: -7860.9% → -16.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.5% | -1.7 pp |
| FY2024 | -14.7% | +4.0 pp |
| FY2023 | -18.7% | +596.7 pp |
| FY2022 | -615.4% | +4829.0 pp |
| FY2021 | -5444.4% | -1545.7 pp |
| FY2020 | -3898.7% | +3962.1 pp |
| FY2019 | -7860.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFMW financial trends
SBFMW RevenueSBFMW Net incomeSBFMW Gross profitSBFMW Gross marginSBFMW Operating incomeSBFMW Operating marginSBFMW Operating cash flowSBFMW Free cash flowSBFMW Capital expendituresSBFMW Return on equitySBFMW Stock buybacksSBFMW Dividends paidSBFMW Total assetsSBFMW Total liabilitiesSBFMW Shareholders’ equitySBFMW overview →